EXTON, Pa., Feb. 16, 2017 /PRNewswire/ -- Absorption Systems, a global leader in nonclinical testing of drugs, biologics, and medical devices, is pleased to announce that its Chief Operating Officer, Sid Bhoopathy, Ph.D., has been selected as a winner of the 2017 Executive Management Award. The award is sponsored by SmartCEO Magazine and recognizes driven executives for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic. The awards ceremony and celebration is on March 8, 2017 at the Ballroom at the Ben in Philadelphia.
Previously, Dr. Bhoopathy was honored as an Emerging Leader by Life Sciences Pennsylvania; and in 2013 he was a recipient of the 40 under Forty, Most Talented Young Leaders by the Philadelphia Business Journal for leadership, vision and commitment to the life sciences industry.
"Everything we do is about furthering our mission of developing research tools for improved human therapeutic outcomes," said Dr. Sid Bhoopathy. "This recognition is a testament to the bold, invested and passionate group of team members whom I work with, to make this possible.
At Absorption Systems, Dr. Bhoopathy directs the convergence of the commercial, technical, and scientific aspects of the company to execute its growth plans. He has led efforts to successfully attain bio-waivers for over fifty branded and generic companies' drug products. Based on his extensive experience, Dr. Bhoopathy is routinely called upon as an expert leader and speaker, to share insights regarding the capabilities and potential of such predictive tools. He is currently applying this knowledge to accelerate and augment equivalence assurance for numerous complex drug products. In 2015, his perspective on the evolution of complex generics development was featured as the cover story of the AAPS Magazine. Dr. Bhoopathy has also held multiple leadership positions within AAPS and is currently the Chair Elect of the Generic Pharmaceuticals Focus Group.
About Absorption SystemsAssisting pharmaceutical and medical device companies, Absorption Systems identifies and overcomes ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. The company's facilities are strategically located on both of the US coasts and in Panama, and encompass nearly 65,000 sq. ft., servicing hundreds of customers throughout the world. For more information on the company's comprehensive contract services and applied research programs, please visit absorption.com.
Chris Bode[email protected]
Advertisement
Previously, Dr. Bhoopathy was honored as an Emerging Leader by Life Sciences Pennsylvania; and in 2013 he was a recipient of the 40 under Forty, Most Talented Young Leaders by the Philadelphia Business Journal for leadership, vision and commitment to the life sciences industry.
Advertisement
"Everything we do is about furthering our mission of developing research tools for improved human therapeutic outcomes," said Dr. Sid Bhoopathy. "This recognition is a testament to the bold, invested and passionate group of team members whom I work with, to make this possible.
At Absorption Systems, Dr. Bhoopathy directs the convergence of the commercial, technical, and scientific aspects of the company to execute its growth plans. He has led efforts to successfully attain bio-waivers for over fifty branded and generic companies' drug products. Based on his extensive experience, Dr. Bhoopathy is routinely called upon as an expert leader and speaker, to share insights regarding the capabilities and potential of such predictive tools. He is currently applying this knowledge to accelerate and augment equivalence assurance for numerous complex drug products. In 2015, his perspective on the evolution of complex generics development was featured as the cover story of the AAPS Magazine. Dr. Bhoopathy has also held multiple leadership positions within AAPS and is currently the Chair Elect of the Generic Pharmaceuticals Focus Group.
About Absorption SystemsAssisting pharmaceutical and medical device companies, Absorption Systems identifies and overcomes ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. The company's facilities are strategically located on both of the US coasts and in Panama, and encompass nearly 65,000 sq. ft., servicing hundreds of customers throughout the world. For more information on the company's comprehensive contract services and applied research programs, please visit absorption.com.
Chris Bode[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/smartceo-executive-management-award-presented-to-dr-sid-bhoopathy-300408922.html
SOURCE Absorption Systems
